Cytovia grants Latin American Ceplene rights to Pint Pharma
Cytovia Inc., the oncology division of Immune Pharmaceuticals Inc., granted Pint Pharma GMBH rights to market and distribute Ceplene (histamine dihydrochloride) for acute myeloid leukemia in Latin America, including Argentina, Brazil, Chile, Colombia, and Mexico.
- Includes Equity
- Includes Royalty or Profit Split Information
- Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com